L-Fucose treatment significantly enhances ENPCs-derived neurogenesis and gliogenesis through suppressing SMAD2 phosphorylation, thus promoting ENS regeneration and gastrointestinal motility recovery in T1DM mice. The gene discussed is SMAD2; the disease is type 1 diabetes mellitus.